Table 2 Protocols in the genomic medicine implementation domain in the PhenX Toolkit.
Protocol name | Protocol source | Description of measurement protocol | Number of items; mode of administration | Languages available; study populationa |
|---|---|---|---|---|
Adoption of Genetic Services: Health-care Settings | Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) Checklist for Study or Intervention Planning4 | The adoption dimension of RE-AIM includes a four-item checklist used to evaluate the characteristics of settings that participate in offering genetic services or a new genetic services intervention. | 4 items; program evaluation | English; health-care providers |
Awareness of Pharmacogenomics | Daud et al.5 | This series of questions can be used to determine an individual’s knowledge of pharmacogenomics (PGx) and if the individual is willing to participate in PGx research. It is beneficial for patients to understand that genetic traits may influence the effects of medications and that clinicians are using PGx for patient safety purposes. | 17 items; self-administered questionnaire | Dutch and English; adults, age 18 and older, and pregnant women |
Baseline Knowledge of Genomics | University of North Carolina Genomic Knowledge Scale (UNC-GKS)6 | The University of North Carolina Genomic Knowledge Scale (UNC-GKS) was developed to assess knowledge domains thought to be critical for making informed decisions about undergoing genomic sequencing (e.g., for medical diagnosis, public health applications, or guiding treatment decision making), comprehending the meaning and limitations of results, and taking appropriate actions upon learning results. | 25 items; self-administered questionnaire | English; adolescents and adults age 17 and older |
Clinician Confidence in Returning Genetic Test Results | Clinical Sequencing Evidence-Generating Research Consortium (CSER), Provider Measures—Post–Return of Results Follow-up #1, Electronic Medical Records and Genomics (eMERGE) Post–Return of Results Provider Follow-up Questionnaire7 | The health-care provider is asked about his or her knowledge of genetic results without seeking information from other sources. A scale with responses from “not at all confident” to “very confident” is used to measure the provider’s confidence. A second set of items refers to the usefulness of the genetic test results with a scale that ranges from strongly disagree to strongly agree. | 9 items; self-administered or interviewer-administered questionnaire | English; health-care providers after sharing the genetic results with the patient |
Information Sources for Patients After Return of Results | Information Seeking V2 from the Clinical Sequencing Evidence-Generating Research (CSER) Adult Patient Measures—Post-Return of Results Follow-up #2 (5–7 months Post-Return of Results)8 | After a patient receives genetic test results, the patient is asked which sources were used to find out more about the genetic test results. Then the patient records a score (using a scale ranging from 1 to 5) based on the perceived usefulness of the information from the source. The patient is also encouraged to list any websites that were helpful. | 4 items; self-administered or interviewer-administered questionnaire | English; adult patients or parents/guardians of a pediatric patient after genetic testing |
Organizational Readiness for Change | Organizational Readiness for Implementing Change (ORIC)9 | Organizational Readiness for Implementing Change (ORIC) is a 12-item instrument used to determine how well employees at an organization feel they can implement the change in processes required by a proposed intervention. Each item includes a Likert scale ranging from 1 (Disagree) to 5 (Agree). | 12 items; program evaluation | English; college students and health-care system employees |
Patient Empowerment After Genetic Services and Counseling—Genomics Outcome Scale (GOS) | Genomics Outcome Scale (GOS)10 | The Genomics Outcome Scale (GOS) is a 6-item version of the 24-item Genetic Counseling Outcome Scale (GCOS-24) and focuses on empowerment as a key outcome following counseling. The GOS includes a 5-point Likert scale eliciting the respondent’s agreement, ranging from strongly disagree (1) to strongly agree (5), with each statement. | 6 items; self-administered questionnaire | English; 18 years and older in United Kingdom |
Patient Response to Genetic Testing | Feelings About genomiC Testing Results (FACToR)11 | The FACToR instrument is used to measure the psychosocial impact of returning genomic findings to patients in research and clinical practice. The instrument includes 12 items and 4 subscales (negative emotions, positive emotions, uncertainty, privacy concerns) with a 5-point Likert scale. | 12 items; self-administered questionnaire | English; patients age 18 and older after genetic testing |
Patient Satisfaction with Genetic Counseling | Genetic Counseling Satisfaction Scale (GCSS)12 | The Genetic Counseling Satisfaction Scale (GCSS) is a 6-item, 5-point Likert scale used to assess patient satisfaction with genetic counseling. | 6 items; self-administered questionnaire | English; adult women after genetic counseling |
Perceived Compatibility with Current Clinical Practice | Implementing GeNomics In pracTicE (IGNITE) Preimplementation Provider Survey13 | There are three items from the IGNITE Preimplementation Provider Survey that health-care providers can use to assess the compatibility and value of a genomic intervention at their clinical practice. Responses are based on a 5-point Likert scale ranging from strongly agree (5) to strongly disagree (1). | 3 items; self-administered questionnaire | English; health-care providers |
Program Evaluation: Patient Uptake of Genetic Services | Reach Effectiveness Adoption Implementation and Maintenance (RE-AIM) Checklist for Study or Intervention Planning4 | The reach dimension of RE-AIM includes a 4-item checklist used to summarize the characteristics of patients who participate in the uptake of services. Genetic service programs or investigators are expected to report these details when describing patient uptake of genetic services. | 4 items; program evaluation | English; health-care providers |
Regret About Health-care Decisions | Decision Regret Scale14 | The Decision Regret Scale is a 5-item Likert scale. Respondents read each statement and use the response options to indicate how much they agree or disagree with the statement. The scale numbers range from strongly agree (1) to strongly disagree (5). | 5 items; self-administered questionnaire | English; adults with cancer or osteoporosis |
Relative Advantage of a Genomic Medicine Intervention over Current Practice | Implementing GeNomics In pracTicE (IGNITE) Preimplementation Provider Survey15 | There are two questions from the IGNITE Preimplementation Provider Survey that health-care providers can use to assess the relative advantage of a genomic intervention over their current practice. Responses are based on a 5-point Likert scale ranging from strongly agree (5) to strongly disagree (1). | 2 items; self-administered questionnaire | English; health-care providers |
Sharing Genomic Information with Relatives | Family Communication from the Clinical Sequencing Evidence-Generating Research (CSER) Adult Patient Measures—Post-Return of Results Follow-up #2 (5–7 months Post–Return of Results) and Electronic Medical Records and Genomics (eMERGE) Family Communication of Genetic Results8 | This series of questions can be used to determine with whom (if anyone) the individual shared his or her genetic tests results and why it was important to share the results. | 5 items; self-administered or interviewer-administered questionnaire | English; adults after genetic testing |
Understanding of Health Implications of Genomics | KnowGene16 | The KnowGene Scale is a 16-item scale administered to patients after genetic testing and/or genetic counseling to measure their understanding of the health implications of genetic testing results. The KnowGene Scale includes health implications to oneself as well as relatives. This measure covers penetrance, actionability, limitations of current technology, and monogenic inheritance patterns. | 16 items; self-administered questionnaire | English; adults after genetic testing |
Supplemental Informationb | ||||
Adherence to Clinical Practice Guidelines for Genomic Medicineb | Tier 1 Genomics Applications and Their Importance to Public Health17 | The Centers for Disease Control and Prevention’s Office of Public Health Genomics developed a toolkit of genomic medicine resources for clinicians, public health professionals, public health agencies, advocates, and community leaders. The resources focus on the following tier 1 conditions: hereditary breast and ovarian cancer syndrome, Lynch syndrome, and familial hypercholesterolemia. | Not applicable; guidelines | English; clinicians and public health professionals |
Intention to Share Genomic Information with Relatives and Othersb | Implementing GeNomics In pracTicE (IGNITE) Patient Preimplementation Survey18 | This question is used to determine with whom (if anyone) the individual plans to share his or her genetic tests results. | 1 item; self-administered questionnaire | English; adults after genetic testing |
Patient Empowerment After Genetic Services and Counselingb | Genetic Counseling Outcome Scale (GCOS-24)19 | The 24-item Genetic Counseling Outcome Scale (GCOS-24) focuses on empowerment. GCOS-24 includes a 7-point Likert scale ranging from how much the individual strongly disagrees (1) to strongly agrees (7) with the statement. GCOS-24 evaluates genetic counseling and testing services. | 24 items; self-administered questionnaire | English; adults after genetic testing and genetic counseling |